This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Patient Safety/ Medical Error  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Leape and colleagues¹ have demonstrated that the inclusion of a pharmacist on medical rounds significantly reduces clinical morbidity and economic costs resulting from preventable adverse drug events (ADEs). However, we believe that a few points deserve comment. In the study group, 45% of the interventions made by a pharmacist participating in rounds involved clarification or correction of an order. In the control group, pharmacists not participating in rounds also had a presence, but it is unclear if they were allowed to make interventions, such as retrospective clarification or correction of drug orders. In many practice settings, such retrospective intervention frequently corrects errors before medications are dispensed or administered to patients. If interventions of any type were done by the pharmacist not participating in rounds, reporting of this behavior would be valuable for assessing differences in intervention patterns between the 2 groups and identifying the types of . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
, , , , , , and
JAMA. ;282():267-270.
FULL TEXT